Application of the Mutual Information to the Zn Gauge Model

We introduce the mutual information to the Zn lattice gauge theory for testing the degree of correlations. It is shown that our simulation result for the plaquettes gives a clear peak on the critical point

北海道医療大学病院インプラント歯科外来の現状

北海道医療大学病院は,2005年7月1日に設備拡充して,新しくスタートした.今回,我々は,2005年7月から2006年6月の1年間に北海道医療大学病院インプラント歯科外来を受診した患者の実態を調査したので報告する.インプラント歯科外来受診者数は,51名であり,紹介患者は24名で紹介率は47%であった.インプラント手術を施行した患者は,49症例であった.インプラント手術件数は67件であり,インプラント埋入本数は201本であった.入院してインプラント手術を施行した症例は63件であった.麻酔方法は,静脈内鎮静法を併用した症例が多く,62/67症例で92.5%であった.インプラントクリニカルパスに従い,インプラント治療を行っており,患者の満足度と安心感に貢献できた治療が可能になったと考える.また,開業医でもインプラント治療が行われるようになり,それら病院より患者の紹介も増加することが予想され,さらに治療のレベルを向上させ,スタッフの充実を図る必要性が考えられた.Hospital of Health Sciences University of Hokkaido was expanded newly on July 1, 2005 and started as a new hospital. At the same time, the facilities and stuff of clinical department of implant dentistry were strengthened remarkably. In late years, the enlightenment spread to patients, who were lost of the teeth, to implant treatment spreads, and come to have a large the expectation degree of the patients. At this time, we have reported having a medical examination status of the implant patients from July, 2005 to June, 2006. We present Hospital of Health Sciences University of Hokkaido Clinical department of implant dentistry outpatient this time between one year of June, 2006 since July, 2005 because the reality of the patient who had a checkup was investigated. Clinical department of implant dentistry examination several were 51 patients, and the introduction patient was 24 patients, and the introduction rate was 47%. Patient who performed implant operation was 49 cases. Case of Implant operation was 67 cases, and implant installed numbers were 201 fixtures. The case that the patients was hospitalized, and performed implant operation was 63 cases. There was much case that used with the intravenous sedation, and the anesthesia cases were 92.5% in 62/67 cases. An implant clinical path is followed, and an implant treatment is being done, and it is thought that satisfaction of the patient and the treatment that were able to contribute to a feeling of relief were enabled. In addition, did an implant treatment with a practicing physician, and that introduction of the patient from the hospital increased was expected, and a more therapeutic level was improved, and necessity to plan substantiality of staff was thought about

Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks (P06125)—Secondary publication

Abstract After completion of a 6‐week double‐blind trial of asenapine sublingual tablets (10 or 20 mg/day) versus placebo in Asian patients with acute exacerbation of schizophrenia, including Japanese patients, this open‐label study evaluated the safety and efficacy of a 52‐week treatment with asenapine at flexible doses. In 201 subjects, including 44 who had received placebo (P/A group) and 157 who had received asenapine (A/A group) in the feeder trial, adverse events occurred at rates of 90.9% and 85.4% and serious adverse events at rates of 11.4% and 20.4%, respectively. One patient in the P/A group died. No clinically significant abnormal measurements of body weight, body mass index, or glycated hemoglobin, fasting plasma glucose, insulin, and prolactin levels were observed. The sustained efficacy rate, as evaluated by the Positive and Negative Syndrome Scale total score and other measures, remained at approximately 50% between 6 and 12 months of treatment. These results suggest that long‐term treatment with asenapine is well tolerated and provides sustained efficacy

Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan

An 84-year-old woman was admitted to our hospital with nonproductive cough and dyspnea on exertion. Computed tomography (CT) scan revealed extensive consolidation in the right lung. She was diagnosed with pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma using CT-guided lung biopsy. Her pulmonary images and respiratory symptoms did not improve two months after receiving 4 cycles of rituximab weekly; therefore, yttrium-90 ibritumomab tiuxetan was chosen as salvage therapy. The abnormal shadow on her pulmonary images was significantly reduced two months later, and she had no symptoms without nonhematological toxicities. She has had no progression for 18 months. Furthermore, radiation pneumonitis has not also been observed. We herein reported bulky pulmonary MALT lymphoma treated with yttrium-90 ibritumomab tiuxetan

Long-term prognosis and clinical characteristics of young adults (≤40 years old) who underwent percutaneous coronary intervention

AbstractBackgroundLimited data exist regarding the long-term prognosis of percutaneous coronary intervention (PCI) in young adults. The aim of this study was to retrospectively assess the long-term clinical outcomes in young patients who underwent PCI.Methods and resultsBetween 1985 and 2011, 7649 consecutive patients underwent PCI, and data from 69 young adults (age ≤40 years) and 4255 old adults (age ≧65 years) were analyzed. A Cox proportional hazards regression analysis was used to determine the independent predictors of a composite endpoint that included all-cause death and acute coronary syndrome (ACS) during the follow-up period. The mean age of the 69 young patients was 36.1±4.9 years, and 96% of them were men. Approximately 30% were current smokers, and their body mass index (BMI) was 26.7±5.0kg/m2. The prevalence of diabetes and hypertension was 33% and 48%, respectively. All patients had ≥1 conventional cardiovascular risk factor. At a median follow-up of 9.8 years, the overall death rate was 5.8%, and new-onset ACS occurred in 8.7%. Current smoking was an independent predictor of the composite endpoint (hazard ratio 4.46, confidence interval 1.08–19.1, p=0.04) for young adults.ConclusionCurrent smoking and obesity (high BMI) are the important clinical characteristics in young Japanese coronary heart disease patients who undergo PCI. The long-term prognosis in young patients is acceptable, but current smoking is a significant independent predictor of death and the recurrence of ACS in young Japanese coronary heart disease patients who are obese